APDN Financial Facts
NET LOSS FROM OPERATIONS: -2.41MDepreciation and amortization: 148.53K
See Full Income Statement
Accounts receivable: 6.37M
Accumulated deficit: 430.19M
See Full Balance Sheet
Applied DNA Sciences (APDN) Earnings
|
Expand Research on APDN
| Next EPS Date | N/A | EPS Growth Rate | -225.5% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +44.8% | Revenue Growth Rate | +37,307.5% *Last Qtr. |
| Average % Move 1-Wk after EPS | -3.4% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/14/25  |
Q325 | -$0.59 | $0.00 | -$0.59 | $299.26M | N/A | N/A |  | | Details | |
| 5/15/25 | Q225 | -$15.35 | $0.00 | -$15.35 | $980K | N/A | N/A | | | Details | |
| 8/8/24 | Q324 | $0.47 | -$3.70 | +$4.17 | $800K | $1.18M | N/A | | | Details | |
| 5/9/24 | Q224 | N/A | -$4.50 | N/A | N/A | $951K | N/A | N/A | N/A | ||
| 2/8/24 | Q124 | -$0.09 | -$0.27 | +$0.18 | $890K | $776.11K | N/A | | | Details | |
| 12/21/23 | Q423 | N/A | -$0.27 | N/A | N/A | $1.68M | N/A | N/A | N/A | ||
| 8/10/23 | Q323 | -$0.24 | -$0.24 | $0.00 | $2.92M | $2.56M | N/A | | | Details | |
| 5/11/23 | Q223 | $0.05 | -$0.20 | +$0.25 | $4.41M | $4.11M | N/A | | | Details |
